SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001740053-22-000003
Filing Date
2022-03-04
Accepted
2022-03-04 16:02:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 dvax.txt SC 13G 5901
  Complete submission text file 0001740053-22-000003.txt   7404
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80035 | Film No.: 22713987
SIC: 2834 Pharmaceutical Preparations

Mailing Address 135 S LASALLE ST SUITE 4200 CHICAGO IL 60603
Business Address 135 S LASALLE ST SUITE 4200 CHICAGO IL 60603 3124292335
Chicago Capital, LLC (Filed by) CIK: 0001740053 (see all company filings)

IRS No.: 823400556 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G